Ricci, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 10.212
AS - Asia 6.188
EU - Europa 5.242
SA - Sud America 1.447
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 16
Totale 23.260
Nazione #
US - Stati Uniti d'America 10.024
SG - Singapore 2.086
CN - Cina 2.065
UA - Ucraina 1.502
BR - Brasile 1.234
IT - Italia 817
HK - Hong Kong 814
DE - Germania 758
FI - Finlandia 446
PL - Polonia 399
GB - Regno Unito 343
VN - Vietnam 324
IN - India 280
TR - Turchia 256
RU - Federazione Russa 246
IE - Irlanda 239
FR - Francia 217
CA - Canada 99
BD - Bangladesh 91
AR - Argentina 80
NL - Olanda 63
MX - Messico 59
ID - Indonesia 56
SE - Svezia 56
ZA - Sudafrica 49
IQ - Iraq 44
EC - Ecuador 39
AT - Austria 33
JP - Giappone 29
ES - Italia 27
MU - Mauritius 24
BE - Belgio 23
CO - Colombia 20
PY - Paraguay 19
VE - Venezuela 19
UZ - Uzbekistan 18
PK - Pakistan 17
EU - Europa 16
AU - Australia 15
IR - Iran 15
MA - Marocco 15
SA - Arabia Saudita 15
CZ - Repubblica Ceca 13
PE - Perù 11
CL - Cile 10
IL - Israele 10
JO - Giordania 10
LT - Lituania 10
PT - Portogallo 10
RO - Romania 10
EG - Egitto 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
UY - Uruguay 8
KE - Kenya 7
ET - Etiopia 6
MY - Malesia 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
LB - Libano 5
MK - Macedonia 5
OM - Oman 5
AM - Armenia 4
CI - Costa d'Avorio 4
DZ - Algeria 4
HN - Honduras 4
NP - Nepal 4
PA - Panama 4
UG - Uganda 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
EE - Estonia 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BH - Bahrain 2
CH - Svizzera 2
FK - Isole Falkland (Malvinas) 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
PH - Filippine 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
HR - Croazia 1
LU - Lussemburgo 1
Totale 23.251
Città #
Fairfield 1.040
Jacksonville 1.013
Singapore 973
Hong Kong 814
Ashburn 812
Woodbridge 711
Houston 551
Chandler 451
Princeton 445
Ann Arbor 426
Cambridge 419
Wilmington 413
Beijing 398
Warsaw 393
Nanjing 374
Seattle 372
New York 318
Dearborn 248
Dublin 235
Istanbul 214
Los Angeles 214
Helsinki 210
The Dalles 141
Des Moines 127
Nanchang 124
Brescia 123
Ho Chi Minh City 123
Milan 116
Munich 116
Moscow 112
São Paulo 106
Buffalo 104
Dallas 97
Shenyang 94
San Francisco 79
Redondo Beach 78
Hebei 74
Jinan 74
Changsha 71
Tianjin 70
Hanoi 63
San Diego 60
Shanghai 60
Chicago 59
Jiaxing 52
Kunming 42
Rio de Janeiro 42
Hangzhou 41
London 41
Lancaster 39
Montreal 38
Santa Clara 36
Verona 36
Nuremberg 34
Brooklyn 32
Turku 32
Guangzhou 31
Boardman 30
Jakarta 30
Ningbo 30
Toronto 29
Rome 26
Tokyo 26
Pune 25
Johannesburg 24
Lanzhou 24
Zhengzhou 24
Frankfurt am Main 22
Stockholm 22
Boston 21
Council Bluffs 21
Romola 21
San Mateo 21
Brasília 20
Mexico City 20
Amsterdam 19
Belo Horizonte 19
Denver 19
Poplar 19
Springfield 19
Charlotte 18
Chennai 18
Phoenix 18
Augusta 17
Curitiba 17
Kocaeli 17
Lappeenranta 17
Porto Alegre 17
Dhaka 16
Orem 16
Tashkent 16
Changchun 15
Fortaleza 15
Leawood 15
Norwalk 15
Atlanta 14
Brussels 14
Ardabil 13
Campinas 13
Hefei 13
Totale 14.456
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 395
Persistent intraepithelial lymphocytosis in celiac patients adhering to gluten-free diet is not abolished despite a gluten contamination elimination diet 280
Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet 247
A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy. 238
13C-urea breath test values and Helicobacter pylori eradication. 185
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection:a randomised controlled trial 179
Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature. 177
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 175
Adalimumab in active ulcerative colitis: A "real-life" observational study. 171
Factors that contribute to hypertransaminasemia in patients with celiac disease or functional gastrointestinal syndromes 167
A new self-administered semi-quantitative food frequency questionnaire to estimate nutrient intake among Italian adults: Development design and validation process 165
Five year time course of celiac disease serology during gluten free diet: results of a community based " CD-Watch" program. 162
Ulcerative colitis and the aging-related development of colonic diverticula 160
Randomised clinical study: Gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity 158
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. 155
A rapid Immunochromatographic assay for Helicobacter pylori in stool before and after treatment 150
Helicobacter pylori infection: anything new should we know? 148
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 148
Absence of Helicobacter pylori in dental plaque assessed by stool test. 147
A rapid, low dose 13C Urea tablet for the detection of Helicobacter pylori infection before and after treatment 145
Celiac disease with mild enteropathy is not mild disease 145
Disegno dello Studio e dati Preliminari del progetto SEELN (Steatosi Epatica non alcolica): Epidemiologia nutrizionale e Lifestyle Medicine 144
High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease 142
Age, Helicobacter pylori and/or CagA antibodies as a pre-endoscopic screening policy 138
Clinical expression of lymphocytic duodenosis in "mild enteropathy" celiac disease and in functional gastrointestinal syndromes 137
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 134
A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 134
Best cut off values for 14C-urea breath tests for Helicobacter pylori detection 130
Letter: Gluten challenge in the era of noncoeliac gluten sensitivity - A change in clinical practice? Author's reply 130
POST-INFECTIOUS IRRITABLE BOWEL SYNDROME FOLLOWING A WATER BORNE nOROVIRUS-eNTEROVIRUS GASTROENTERITIS OUTBREAK. 129
Stool test for Helicobacter pylori 128
Editorial: Noncoeliac gluten sensitivity - The controversy rages on. Authors' reply 128
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis 127
A serologic survey of Helicobacter pylori infection in 3281 patients endoscoped for upper gastrointestinal symptoms through Italia 127
Helicobacter pylori: diseases, tests and treatment 126
Diagnosis of Helicobacter pylori infection: which is the best test? Stool test 125
High eradication rates for Helicobacter pylori with a new sequential treatment 124
Non invasive antigen based assay for assessing Helicobacter pylori eradication. A European multicenter study 124
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 124
Diagnosis and treatment of Helicobacter. A 2002 Updated review 123
Stool test for Helicobacter pylori 123
Helicobacter pylori: storia e tassonomia 121
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 120
The multidisciplinary team for management of inflammatory bowel diseases 119
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial. 118
Rifaximin suspension for the eradication of Helicobacter pylori 118
Peptic ulcer and Helicobacter pylori. 118
Five year time course of celiac disease serology during gluten free diet: Results of a community based " CD-Watch" program 118
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 118
Duodenal histological features in suspected non-celiac gluten sensitivity: new insights into a still undefined condition 118
How valuable is the application on Consensus guidelines in the management of functional gastrointestinal disorders 117
Usefulness of serology in preendoscopic screening 117
Four years time course of celiac disease (CD) serology during gluten free diet (GFD) resluts of a community based program. 117
Amoxicillin-clavulanate-induced ischaemic colitis 117
IgG Elisa antibodies and detection of Helicobacter pylori in elderly patients 116
HLA gene dose effect and helicobacter pylori infection do not contribute to persistence od intraepithelial lymphocitosis frequently observed in celiac patients adherent to gluten free diet. 115
A Prospective Clinical Trial on Safety and Efficacy of Antiviral Treatment of Chronic Hepatitis C in Active Illicit Drug Users 114
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 114
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 113
C-Urea Breath Test Values and Helicobacter pylori Eradication 113
A second-line anti-Helicobacter pylori in theray in patients with previously failed treatment 112
Blood tests in management of Helicobacter pylori infection 112
Exhaled nitric oxide as a marker of lung involvement in Crohns disease. 112
Is villous atrophy predictable by high tissue-transglutaminases antibodies (T-Tga) level in unselected adult patients evaluated for celiac disease (CD) ? 112
Tissue transglutaminases antibodies (T-TGA) level as predictor of villous atrophy among adult unselected patients twith sispected celiac disease (CD 112
The Italian Registry of Therapeutic Apheresis: Granulocyte_Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease. A Multicentric Study 111
Evaluation of systo-diastolic cardiac function and arterial stiffness in subjects with new diagnosis of coeliac disease without cardiovascular risk factors. 111
CARDIOVASCULAR RISK FACTORS ARE AFFECTED BY GLUTEN FREE DIET (GFD) IN CELIAC DISEASE (CD): RESULTS IN A COHORT OF 765 PATIENTS. 110
Authors' replay: Comment to "High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease" 110
Incidence of post-infectious irritable bowel sydrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak 109
Are cardiovascular rik factors affected by gluten free diet in celiac patients? Results in a cohor of 765 patients. 109
Potential celiac disease is not a mild disease: a single unit study in a color of 1140 patients 109
Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection. 109
Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery. 108
Is severity of duodenal histopatology morrored by differences in clinical and laboratory presentation in celiac disease ? A single unit study in a cohort of 1140 patients. 108
Postinfectious functional intestinal disorders following a waterborn norovirus gastroenteritis our break 108
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance 107
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. 107
Symptoms and Helicobacter pylori, any link 107
Celiac disease in the elderly: clinical, serological and histological characteristics, and effect of gluten free diet 107
Persistence of intraepithelial lymphocytosis in celiac patietns adherent to gluten free diet: is there a HLA gene dose effec or a role for Helicobacter pylori infection ? 107
Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection in the pre- treatment assessment and in patients on omeprazole therapy 106
Celiac diseases at the time of diagosis in a cohort of 793 patietnts: age-related differences in clinical, serological and histopathogogical features. 106
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy 105
Helicobacter pylori status, endoscopic findings, and serology in HIV-1 -positive patients 105
Celiac dsease at the time of dianosis: age-relted differences in clinical, serological and histopathological features 105
HLA gene dose effect does not contribute to persistence of intraepithelial lymphocytosis frequently observed in celiac patientis adherent to gluten free diet. 105
five years time-course of transglutaminases (t-TG) antibodies and adherence to gluten free population based program. 105
Accuracy of the stool antigen test in the pre- and post-eradication diagnosis of Helicobacter pylori infection, and in patients on omeprazole therapy 104
Regional differences of mucosal hydrophobicity in the gastrointestinal tract of healthy subjects 104
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 103
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients. 103
Gastroesophageal reflux disease and Barrett's esophagus. 103
Novel steps forward in the histopathology of non-celiac gluten sensitivity, authors’ reply 103
Accurate diagnosis of Helicobacter pylori: stool tests 102
Newer agents for Helicobacter pylori eradication 102
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 101
Diagnosis of Helicobacter pylori infection: faecal antigen determination 101
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 101
Increased serum gammaglutamyltranspeptidase activity: a surrogate marker of non alcoholic hepatic steatosis in chronic hepatitis C? . 100
Totale 12.976
Categoria #
all - tutte 118.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.862 0 0 0 0 0 302 69 375 449 235 363 69
2021/20221.643 71 299 24 117 30 77 62 129 93 188 184 369
2022/20231.465 258 32 45 100 111 433 5 132 207 12 68 62
2023/20241.763 86 38 81 161 97 381 71 50 445 33 27 293
2024/20253.996 33 34 36 429 484 342 335 129 427 359 837 551
2025/20264.905 798 1.187 670 1.310 833 107 0 0 0 0 0 0
Totale 23.550